Regarding the importance of the NLRP3 inflammasome in PD pathogenesis and its therapeutic potential, the findings of our study indicated that MSC infusion might target the NLRP3 inflammasome to exert anti-inflammatory effects in the central system and periphery in PD mice. This evidence concerns the gene NLRP3 and Parkinson disease.